Weed Nation App

News and articles

Apr 02
New Report Published: “Reimbursement Pathways for Psychedelic Therapies Across Europe”

A new report, “Reimbursement Pathways for Psychedelic Therapies Across Europe”—funded by Norrsken Mind and co-authored by Martin Gisby and Floris Wolswijk—dives deep into one of the most pressing questions in psychedelic policy today: how do we ensure equitable, timely access to novel psychedelic treatments? The report examines how European healthcare systems currently fund innovative mental health […]

Apr 02
Article: Italian mafia experts help gardaí to bring down ‘The Family’, Ireland’s major drug trafficking network

Twelve arrests – six here and six in Spain – crippled cocaine importation operation of the gang that filled void left in the wake of Kinahan/Hutch feud Italian Mafia police experts are advising An Garda Síochána on how to take down Ireland’s number-one drug trafficking network, the west-Dublin crime gang known as The Family. On […]

Apr 02
FBI Denies Delaware’s Background Check Request, Delaying Adult-Use Cannabis Sales Launch

The federal agency’s standard collides with Delaware Code, forcing the state’s cannabis regulators to work with lawmakers to draft new legislation. Cannabis Business Times Delaware’s plan to commence adult-use cannabis sales this spring has been upended. State cannabis regulators with the Office of the Marijuana Commissioner (OMC) announced March 31 that the Federal Bureau of Investigation […]

Apr 02
Article: Oregon has spent $46 million fighting black market cannabis. Officials can’t tell if it’s working

The tales of illicit cannabis operations were coming from all corners of Oregon, and by 2018 — four years after the state voted to legalize recreational weed — lawmakers were feeling the pressure to act. Workers on unlicensed grows just miles north of California were sleeping in shipping containers and being held on site by armed guards. […]

Apr 02
Filament Health posts $5M loss in 2024, faces liquidity concerns

Green Market Report The clinical-stage natural psychedelic company showed progress in its drug development pipeline while dealing with a shrinking runway. Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) reported a net loss of $4.97 million for 2024 while the botanical psychedelic drug developer expanded its clinical trial programs and intellectual property portfolio.   https://www.greenmarketreport.com/filament-health-posts-5m-loss-in-2024-faces-liquidity-concerns/

Apr 02
Report: Cocaine connections: Links between the Western Balkans and South America

    Over the last two decades, criminal networks from Albania, Bosnia and Herzegovina, Kosovo, Montenegro, North Macedonia, and Serbia have transitioned from regional actors to key players in the global cocaine supply chain. These groups have forged strategic relationships with coca producers, criminal organizations, and business circles across South America, especially in Colombia, Peru, […]